| Literature DB >> 33652903 |
Brandon Khor1, Michael Snow1, Elisa Herrman1, Nicholas Ray1, Kunal Mansukhani1, Karan A Patel1, Nasser Said-Al-Naief2, Tom Maier2, Curtis A Machida2.
Abstract
The human microbiota represents a complex array of microbial species that influence the balance between the health and pathology of their surrounding environment. These microorganisms impart important biological benefits to their host, such as immune regulation and resistance to pathogen colonization. Dysbiosis of microbial communities in the gut and mouth precede many oral and systemic diseases such as cancer, autoimmune-related conditions, and inflammatory states, and can involve the breakdown of innate barriers, immune dysregulation, pro-inflammatory signaling, and molecular mimicry. Emerging evidence suggests that periodontitis-associated pathogens can translocate to distant sites to elicit severe local and systemic pathologies, which necessitates research into future therapies. Fecal microbiota transplantation, probiotics, prebiotics, and synbiotics represent current modes of treatment to reverse microbial dysbiosis through the introduction of health-related bacterial species and substrates. Furthermore, the emerging field of precision medicine has been shown to be an effective method in modulating host immune response through targeting molecular biomarkers and inflammatory mediators. Although connections between the human microbiome, immune system, and systemic disease are becoming more apparent, the complex interplay and future innovations in treatment modalities will become elucidated through continued research and cross-disciplinary collaboration.Entities:
Keywords: gut microbiome; inflammatory disorders; microbial dysbiosis; oral microbiome; precision medicine; systemic health and disease; therapeutics
Year: 2021 PMID: 33652903 PMCID: PMC7996936 DOI: 10.3390/microorganisms9030496
Source DB: PubMed Journal: Microorganisms ISSN: 2076-2607